Brief: Xilio Therapeutics Announces Pipeline And Business Updates And Q2 Financial Results
14/08/2023 12:40
Aug 14 (Reuters) - Xilio Therapeutics Inc XLO.O :
* XILIO THERAPEUTICS ANNOUNCES PIPELINE AND BUSINESS UPDATES
AND
SECOND QUARTER 2023 FINANCIAL RESULTS
* XILIO THERAPEUTICS INC - ENDED Q2 OF 2023 WITH $75.4
MILLION IN
CASH AND CASH EQUIVALENTS, WITH CASH RUNWAY ANTICIPATED INTO END
OF Q2 OF 2024
* XILIO THERAPEUTICS INC - ANTICIPATE REPORTING PRELIMINARY
PHASE
1/2 DATA FOR XTX202, A TUMOR-ACTIVATED IL-2, IN EARLY NOVEMBER
2023
* XILIO THERAPEUTICS INC - ANTICIPATE REPORTING PRELIMINARY
PHASE
1 SAFETY DATA FOR XTX301, A TUMOR-ACTIVATED IL-12, IN Q4 OF 2023
Source text for Eikon: ID:nGNX9vfxYP
Further company coverage: XLO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla